Regeneron Pharmaceuticals | REGN - Capitalização De Mercado





Capitalização De Mercado Alterar Data
AbbVie USD 435.86B 8.73B 2026-08
Agenus USD 3.19B 3.06B 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 209.65B 14.21B 2026-08
Astellas Pharma JPY 4.1T 160.64B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Kyowa Hakko Kirin JPY 1.28T 76.58B 2026-08
Merck USD 324.18B 6.81B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pfizer USD 143.89B 5.44B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Sarepta Therapeutics USD 1.5B 402M 2026-08
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
United Therapeutics USD 24.42B 1.42B 2026-08
Vertex Pharmaceuticals USD 121.59B 4.48B 2026-08